Participants
T2DM
We invited patients with T2DM aged 20 to 80 to participate in this study. In a 3-week run-in period, volunteers were screened using standard medical history, biochemical tests, liver elastography, and Echocardiography (Supplement Patients with HbA1c greater than 7% and less than 10.5%, a controlled attenuation parameter (CAP) of ≥ 302 dB/m [